Flu Vaccines Take Months to Make. Here’s What Could Speed Them Up

Flu Vaccines Take Months to Make. Here’s What Could Speed Them Up

Every fall, Canadians line up for their annual flu shot — an essential tool to prevent serious illness, hospitalizations, and complications like pneumonia. But what most people don’t realize is that seasonal influenza vaccines take more than six months to manufacture, and the way they’re made hasn’t changed much since the 1940s.

At Destinations Travel Clinic (DTC), where physicians, nurses, and certified travel-medicine pharmacists specialize in immunization and global health, we keep a close eye on vaccine innovation. Faster, more adaptable flu vaccines could save lives, improve seasonal protection, and strengthen Canada’s public-health response.

Below, we break down why flu vaccines take so long to make — and which modern technologies are poised to speed things up.

Why Flu Vaccines Take So Long to Produce

For over 80 years, most flu vaccines have been produced using fertilized chicken eggs. Manufacturers inject the virus into the eggs, allow it to grow, harvest it, purify it, inactivate it, and finally prepare it for use in vaccines.
This system works — but it comes with major limitations:

Long Production Timeline

The World Health Organization selects vaccine strains six months in advance.
Manufacturers need months to grow, purify, and inactivate the virus in millions of eggs.
The lengthy timeline makes it challenging to keep up with flu strains that mutate quickly.

Egg-Adaptation Problems

Influenza viruses grown in eggs often adapt to the avian environment. This can cause:

  • Genetic changes in the virus
  • A final vaccine that is less closely matched to circulating human strains
  • Reduced effectiveness in some years

mRNA Flu Vaccines: A Promising Leap Forward

The same mRNA technology used in COVID-19 vaccines is now being applied to influenza — and the early results are promising.

A Phase 3 clinical trial recently published in the New England Journal of Medicine compared Pfizer’s mRNA flu vaccine to a traditional egg-based vaccine.
Results showed:

34% greater effectiveness

in preventing laboratory-confirmed flu.

This is an important proof of concept that a faster, more flexible vaccine platform could improve protection during unpredictable flu seasons.

While mild side effects like fever and chills were more common, scientists expect future refinements to reduce these reactions.

Cell-Based Flu Vaccines: Faster and Egg-Free

Another advancement already available in Canada is the cell-based influenza vaccine.
Instead of using eggs, these vaccines grow the virus in canine kidney cells, which eliminates problems caused by avian adaptation.

Key advantages:

  • Faster production
  • Potentially better match to human strains
  • Reduced risk of egg-related mutations

Main drawback:

  • Higher cost, which limits wide adoption in public programs

Recombinant Vaccines: Manufactured Without a Live Virus

Canada also has a recombinant (lab-made) flu vaccine. These vaccines:

  • Do not require eggs or live virus
  • Are created using genetic engineering techniques in insect cells
  • Offer a rapid and scalable production method

This platform can respond more quickly to sudden strain changes — a major advantage during severe flu seasons.

The Future: Inhaled and Mucosal Flu Vaccines

Researchers in Canada are working on aerosolized flu vaccines administered through the airways (similar to an inhaler).

Potential benefits:

  • Stronger protection at the mucosal surfaces where infection begins
  • Longer-lasting, multi-season immunity
  • Better defence against both seasonal and pandemic influenza viruses

This technology is still in the pre-clinical stage, but early results are promising.

What This Means for Canadians

Despite exciting advances, Canada’s flu supply will remain mostly egg-based in the near future simply because it is:

  • Well-established
  • Scalable
  • Effective at preventing severe disease

But as newer technologies mature, Canadians may soon see:

  • More effective flu seasons
  • Faster vaccine updates
  • More manufacturing done domestically (“onshoring”)
  • Greater resilience against influenza outbreaks

At Destinations Travel Clinic, our medical team stays at the forefront of these advances to ensure that patients receive the highest-quality, evidence-based immunization care available.

Why Get Your Flu Shot at Destinations Travel Clinic?

DTC is not a retail pharmacy counter. We are a specialized travel and immunization medical centre staffed primarily by:

  • Physicians specializing in travel and infectious diseases
  • Nurses trained in immunization and public health
  • Pharmacists certified in travel medicine

We provide:

  • Clinical assessment
  • Vaccine counselling
  • Risk-based decision-making
  • Management of allergies, contraindications, and complex cases
  • Access to advanced vaccines and travel-specific immunizations

This level of expertise helps ensure safer, more personalized flu protection, especially for high-risk patients, frequent travellers, seniors, and those with chronic conditions.

Stay Connected with Destinations Travel and Immunization Clinic!

If you found this article helpful, don’t forget to like, share, and Follow to stay up to date on our latest travel health tips, updates, and wellness advice.

And follow us on social media

Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied upon for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.